Table 3 Demographic, clinical, and biological characteristics of patients
Total (n = 102) | |
Characteristics at ICU admission | |
Male sex, n (%) | 75 (73.5%) |
Age (years), median (IQR) | 54.62 ± 19.59, 57 (39.75–70.75) |
Medical patients, n (%) | 39 (38.2%) |
Surgery patients, n (%) | 63 (61.8%) |
Prior antibiotics in 90 days, n (%) | 61 (59.8%) |
Characteristics upon VAP onset | |
ICU stay (days), median (IQR) | 37.87 ± 80.45, 8 (4.00–37.75) |
Duration of MV* (days), median (IQR) | 35.42 ± 80.05, 7 (4.00–32.50) |
Septic shock, n (%) | 57 (55.9%) |
new or persistent infiltrate on chest radiography | 72 (70.59%) |
CPIS | 6.59 ± 1.70, 7 (5.00–8.00) |
CRP | 84.59 ± 57.98, 69.45 (46.00–104.80) |
PCT | 17.34 ± 24.29, 10 (2.34–21.30) |
Antibiotics within 3 days | |
None | 5 (4.9%) |
Monotherapy | 41 (40.2%) |
Combination antibiotic therapy | 56 (54.9) |
covering PA | 76 (74.5%) |
Change of antibiotics, n (%) | 45 (44.1%) |
Clinical diagnosis of VAP | 68 (66.7%) |